Loading [Contrib]/a11y/accessibility-menu.js
Editorial

Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)

  • Received: 04 December 2015 Accepted: 23 May 2016 Published: 30 May 2016
  • The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Committee Opinion No. 573 “ Magnesium Sulfate Use in Obstetrics” , which supports the short term use of MgSO4 to prolong pregnancy (up to 48 hrs.) to allow for the administration of antenatal corticosteroids.” Are these pronouncements by respected organizations short sighted and will potentially result in more harm than good? The FDA safety communication focuses on bone demineralization (a few cases with fractures) with prolonged administration of MgSO4 (beyond 5–7 days). It cites 18 case reports in the Adverse Event Reporting System with an average duration of magnesium exposure of 9.6 weeks (range 8–12 wks). Other epidemiologic studies showed transient changes in bone density which resolved in the short duration of follow up. Interestingly, the report fails to acknowledge the fact that these 18 fetuses were in danger of PTD and the pregnancy was prolonged by 9.6 weeks (e.g. extending 25 weeks to 34.6 wks), thus significantly reducing mortality and morbidity. Evidence does support the efficacy of MgSO4 as a tocolytic medication. The decision to use magnesium, the dosage to administer, the duration of use, and alternative therapies are physician judgments. These decisions should be made based on a reasonable assessment of the risks of the clinical situation (PTL) and the treatments available versus the benefits of significantly prolonging pregnancy.

    Citation: John P. Elliott, John C. Morrison, James A. Bofill. Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)[J]. AIMS Public Health, 2016, 3(2): 348-356. doi: 10.3934/publichealth.2016.2.348

    Related Papers:

    [1] Fawaz Dabea Alshammari, Hussain Gadelkarim Ahmed, Dena Alshammari, Ahmed Mulfy Alharbi, Atif Saud Alsaedi, Abdulbaset Elasbaly . Population insight of the relationship between lifestyle and cancer: A population-based survey. AIMS Public Health, 2019, 6(1): 34-48. doi: 10.3934/publichealth.2019.1.34
    [2] Alfred M Levine, Donna B Gerstle . Female breast cancer mortality in relation to puberty on Staten Island, New York. AIMS Public Health, 2020, 7(2): 344-353. doi: 10.3934/publichealth.2020029
    [3] Kai Cheng, Jiangtao Wang, Jian Liu, Xiangsheng Zhang, Yuanyuan Shen, Hang Su . Public health implications of computer-aided diagnosis and treatment technologies in breast cancer care. AIMS Public Health, 2023, 10(4): 867-895. doi: 10.3934/publichealth.2023057
    [4] Md Jahoor Alam, Abdullah Ibrahim Alnafeesah, Mohd Saeed . Inter-correlation of risk factors among heart patients. AIMS Public Health, 2020, 7(2): 354-362. doi: 10.3934/publichealth.2020030
    [5] Erin Linnenbringer, Sarah Gehlert, Arline T. Geronimus . Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression. AIMS Public Health, 2017, 4(5): 526-556. doi: 10.3934/publichealth.2017.5.526
    [6] Saleh Hadi Alharbi, Fahad A. Alateeq, Ibrahim Bin Ahmed, AbdulRahman Ali A. Alsogair, Yousef Duhaim A. Al-Rashdi, Thamer Z. Aldugieman, Hussain Gadelkarim Ahmed . Assessment of levels of awareness towards blood donation in Saudi Arabia. AIMS Public Health, 2018, 5(3): 324-337. doi: 10.3934/publichealth.2018.3.324
    [7] Lee R Mobley, Tzy-Mey (May) Kuo . Geographic and Demographic Disparities in Late-stage Breast and Colorectal Cancer Diagnoses Across the US. AIMS Public Health, 2015, 2(3): 583-600. doi: 10.3934/publichealth.2015.3.583
    [8] Ali Alshahrani . Knowledge, attitudes, and practice of community pharmacists towards providing counseling on vitamins, and nutritional supplements in Saudi Arabia. AIMS Public Health, 2020, 7(3): 697-712. doi: 10.3934/publichealth.2020054
    [9] Emmanuel Kwateng Drokow, Clement Yaw Effah, Clement Agboyibor, Jemima Twumwaah Budu, Francisca Arboh, Priscilla Akyaa Kyei-Baffour, Yao Xiao, Fan Zhang, Irene XY Wu . Microbial infections as potential risk factors for lung cancer: Investigating the role of human papillomavirus and chlamydia pneumoniae. AIMS Public Health, 2023, 10(3): 627-646. doi: 10.3934/publichealth.2023044
    [10] Soo-Foon Moey, Aaina Mardhiah Abdul Mutalib, Norfariha Che Mohamed, Nursyahirah Saidin . The relationship of socio-demographic characteristics and knowledge of breast cancer on stage of behavioral adoption of breast self-examination. AIMS Public Health, 2020, 7(3): 620-633. doi: 10.3934/publichealth.2020049
  • The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Committee Opinion No. 573 “ Magnesium Sulfate Use in Obstetrics” , which supports the short term use of MgSO4 to prolong pregnancy (up to 48 hrs.) to allow for the administration of antenatal corticosteroids.” Are these pronouncements by respected organizations short sighted and will potentially result in more harm than good? The FDA safety communication focuses on bone demineralization (a few cases with fractures) with prolonged administration of MgSO4 (beyond 5–7 days). It cites 18 case reports in the Adverse Event Reporting System with an average duration of magnesium exposure of 9.6 weeks (range 8–12 wks). Other epidemiologic studies showed transient changes in bone density which resolved in the short duration of follow up. Interestingly, the report fails to acknowledge the fact that these 18 fetuses were in danger of PTD and the pregnancy was prolonged by 9.6 weeks (e.g. extending 25 weeks to 34.6 wks), thus significantly reducing mortality and morbidity. Evidence does support the efficacy of MgSO4 as a tocolytic medication. The decision to use magnesium, the dosage to administer, the duration of use, and alternative therapies are physician judgments. These decisions should be made based on a reasonable assessment of the risks of the clinical situation (PTL) and the treatments available versus the benefits of significantly prolonging pregnancy.


    [1] ACOG Practice Bulletin No. 127 Management of Preterm Labor. June 2012.
    [2] U.S. Food and Drug Administration Drug Safety Communication. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. 05/30/2013.
    [3] ACOG Committee Opinion, No. 573. (2013) Magnesium Sulfate Use in Obstetrics. Obstet Gynecol 122: 727-8.
    [4] Vintzileos, AM. (2009) Evidence-Based Compared With Reality-Based Medicine in Obstetrics. Obstet Gynecol 113: 1335-40.
    [5] Evidence-Based Medicine Working Group. (1992) Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine. JAMA 268:2420-5. doi: 10.1001/jama.1992.03490170092032
    [6] Sackett, DL. (1997) Evidence-Based Medicine. Seminar Perinatol 21: 3-5. doi: 10.1016/S0146-0005(97)80013-4
    [7] Steer CM, Petrie, RH. (1977) A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 29: 1-4.
    [8] Elliott JP. (1983) Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 147: 277-84. doi: 10.1016/0002-9378(83)91111-0
    [9] Elliott JP, Lewis DF, Morrison JC. (2009) In Defense of Magnesium Sulfate. Obstet Gynecol 113: 1341-7.
    [10] Ma L. (1992) Magnesium sulfate in the prevention of preterm labor (translation). Chung Hua I Hsveh Chin Taipla 72: 158-61.
    [11] Fox MD, Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. (1993) Neonatal morbidity between 34 and 37 weeks gestation. J Perinatol XIII: 349-53.
    [12] Cox SM, Sherman ML, Leveno KJ. (1990) Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 163 (3): 568-72.
    [13] Elliott JP. (1990) Letter to the editor- Sub therapeutic doses of magnesium sulfate do not inhibit preterm labor. Am J Obstet Gynecol 163: 568.
    [14] Mercer BM and Merlino AA. (2009) Magnesium Sulfate Preterm Labor and Preterm Birth. Am J Obstet Gynecol 114: 650-66.
    [15] Hung J, Tsai M, Yang B. (2005) Maternal Osteoporosis After Prolonged Magnesium Sulfate Tocolysis therapy: A Case Report. Arch Phys Med Rehabil 86: 146-9. doi: 10.1016/j.apmr.2004.02.016
    [16] Conde-Agudelo A, Romero R. (2009) Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks gestation. Am J Obstet Gynecol 200: 595-609. doi: 10.1016/j.ajog.2009.04.005
    [17] ACOG Committee Opinion No. 455. Magnesium sulfate before anticipated preterm birth for neuroprotection. March 2010.
    [18] Scott JR. (2009) Magnesium Sulfate for neuroprotection. What do we do now? Obstet Gynecol 114: 500-01.
    [19] Reeves SA, Gibbs RS, and Clark SL. (2011) Magnesium for fetal neuroprotection. Am J Obstet Gynecol 204: 202.e1-4.
    [20] Mittendorf R, Covert R, Bowman J, et al. (1997) Is tocolytic magnesium sulfate associated with increased total pediatric mortality. Lancet 350: 1517-8. doi: 10.1016/S0140-6736(97)24047-X
    [21] Crowther CA, Hiller JE, Doyle LW, Haslam RR. (2003) Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290: 2669-76. doi: 10.1001/jama.290.20.2669
    [22] Farkouh LJ,Thorp JA, Jones PG, Clark RH, Knox GE. (2001) Antenatal magnesium exposure and neonatal demise. Am J Obstet Gynecol 185: 869-72. doi: 10.1067/mob.2001.117362
    [23] Mittendorf R, Dambrosia J, Pryde PG, et al. (2002) Associationbetween the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 186: 1111-8. doi: 10.1067/mob.2002.123544
    [24] Elliott JP, Morrison JC. The Evidence Regarding Maintenance Tocolysis. Obstetrics and Gynecology International Hindawi Publishing Corporation. Vol 2013, Article ID 708023, 11 pages. Available from: http://dx.doi.org/10.1155/2013/708023.
    [25] Yokoyama K, Takahashi N, Yada Y. (2010) Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev 86: 187-91. doi: 10.1016/j.earlhumdev.2010.02.007
    [26] Wedig KE, Kogan J, Schorry EK et al. (2006) Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 26: 371-4. doi: 10.1038/sj.jp.7211508
    [27] Malaeb SN, Rassi A, Haddad MC. (2001) Bone mineralization in newborns whose mothers received magnesium sulfate for tocolysis of premature labor. Pediatr Radiol 34: 384-6.
    [28] Kaplan W, Haymond MW, Mckay S, Karaviti LP. (2006) Osteopenic effects of magnesium sulfate in multiple pregnancies. J Pediatric Endocrinology and Metabolism 19:1225-30.
    [29] Nassar AH, Sakhel K, Maarouf H et al. (2006) Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scan 19: 1225-30.
    [30] Schanier RJ, Smith LG, Burns PA. (1997) Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest 43: 236-41. doi: 10.1159/000291864
    [31] Doyle LE, Anderson PJ, Haslam R, et al. (2014) School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs. placebo. JAMA 312(11): 1105-13.
    [32] ACOG Practice Bulletin No. 33. (2002) Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Obstet Gynecol 99: 159-67.
    [33] Keys S, Elliott JP. (1997) The therapeutic use of vaginal pessary as adjunctive treatment in patients with multiple gestations presenting with preterm labor and low fetal station. J Reprent Med 42: 751-5.
  • This article has been cited by:

    1. Shadi Alkhayyat, Mona Khojah, Masaheer AlJehan, Daniah Allali, Almoutaz Tayeb, Sultan Albukhari, N Qusty, R Al-Wassia, R Baljoon, Awareness of Colorectal Cancer in Saudi Arabia: Cross-Sectional Study, 2021, 12, 2229-5402, 38, 10.51847/f5Z7stoOfT
    2. Nazim Faisal Hamid, Fayez Muawwadh Albalawi, Abdulrahman Abdullah Aloufi, Rawapy Ali Hamas, Nasser Awadh H Alanazi, Tariq Hulayyil Alanazi, Epidemiological Trends in Childhood Cancer in Saudi Arabia, 2022, 11, 2278-0513, 42, 10.51847/TkpqjgHEDQ
    3. Hussah M. Alobaid, Maha H. Daghestani, Nawal M. AL-Malahi, Sabah A. Alzahrani, Lina M. Hassen, Dina M. Metwally, Exploring the effect of silver nanoparticles on gene expression in colon cancer cell line HCT116, 2022, 11, 2191-9550, 1108, 10.1515/gps-2022-0094
    4. Adnan Alharbi, Cost-effectiveness of Tamoxifen versus Anastrozole in post-menopausal women with breast cancer: Saudi Arabia perspective, 2022, 1658-905X, 8, 10.37881/jmahs.122
    5. Nada E Algethami, Amjad A Althagafi, Rawan A Aloufi, Fawaz A Al Thobaiti , Hamma A Abdelaziz, Invasive Lobular Carcinoma of the Breast With Rectal Metastasis: A Rare Case Report, 2022, 2168-8184, 10.7759/cureus.23666
    6. Basim Saleh Samman, Albadr Hussein, Razan Saleh Samman, Abdulaziz Saud Alharbi, Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review, 2022, 2168-8184, 10.7759/cureus.23952
    7. Laila Naif Al-Harbi, Ghedier M. Al-Shammari, Pandurangan Subash-Babu, Mohammed A. Mohammed, Roaa Ahmed Alkreadees, Abu ElGasim Ahmed Yagoub, Cinchona officinalis Phytochemicals-Loaded Iron Oxide Nanoparticles Induce Cytotoxicity and Stimulate Apoptosis in MCF-7 Human Breast Cancer Cells, 2022, 12, 2079-4991, 3393, 10.3390/nano12193393
    8. Mohammed Alessa, Maryam O Alarfaj, Hanan A Albenayyan, Almaha A Aleidan, Fatimah A Albahrani, May A Bokhuwah, Raghad M Bukhamsin, Razan M Alzahrani, Mohammed F Alkhalifah, Lamees A Alshekhmobarak, Hajar K Alsaleem, Renad S AlSubaie, Dalal A Almulhim, Aisha A AlJughaiman, Lama A Alobaid, Awareness of the Link Between the Consumption of Ultra-Processed Food and Colorectal Cancer Risk in Saudi Arabia, 2023, 2168-8184, 10.7759/cureus.33774
    9. Consuela Cheriece Yousef, Mansoor Ahmed Khan, Hind Almodaimegh, Majed Alshamrani, Meteb O. Alfoheidy, Hana AlAbdalkarim, Ahmed AlJedai, Anjum Naeem, Ivo Abraham, Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: Simulation study, 2023, 1369-6998, 1, 10.1080/13696998.2023.2183680
    10. Ali G Alghamdi, Zahraa Jumah A Almuhanna, Zainab Hussain M Bu Hulayqah, Fatimah Abdulaziz G Algharsan , Hashim A Alghamdi, Hadeel A Alzahrani , Public Awareness of Colorectal Cancer Screening in the Al-Baha Region, Saudi Arabia, 2022, 2022, 2168-8184, 10.7759/cureus.32386
    11. Anfal Mohammed Alenezi, Ashokkumar Thirunavukkarasu, Farooq Ahmed Wani, Hadil Alenezi, Muhannad Faleh Alanazi, Abdulaziz Saud Alruwaili, Rasha Harbi Alashjaee, Faisal Harbi Alashjaee, Abdulaziz Khalid Alrasheed, Bandar Dhaher Alshrari, Female Healthcare Workers’ Knowledge, Attitude towards Breast Cancer, and Perceived Barriers towards Mammogram Screening: A Multicenter Study in North Saudi Arabia, 2022, 29, 1718-7729, 4300, 10.3390/curroncol29060344
    12. Jumanah T Qedair, Abdullah A Al Qurashi, Turki Alfayea, Hatan Mortada, Ali Alsudais, Saleh Almuntashiri, Alqassem Y Hakami, Level and predictors of breast cancer awareness among Saudi women: A nationwide study, 2022, 18, 1745-5057, 174550572211338, 10.1177/17455057221133835
    13. Abdulrahman S. Bazaid, Ahmed A. Punjabi, Abdu Aldarhami, Husam Qanash, Ghaida Alsaif, Hattan Gattan, Heba Barnawi, Bandar Alharbi, Abdulaziz Alrashidi, Abdulaziz Alqadi, Bacterial Infections among Patients with Chronic Diseases at a Tertiary Care Hospital in Saudi Arabia, 2022, 10, 2076-2607, 1907, 10.3390/microorganisms10101907
    14. Hussain Alyousif, Ishag Adam, Naser A. Alamin, Mona A. Sid Ahmed, Ayat Al Saeed, Abdulmuhsen Hussein Hassoni, Imad R. Musa, The prevalence and associated predictors for Bethesda III–VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia, 2022, 13, 2042-0188, 204201882211224, 10.1177/20420188221122486
    15. Ahmed M. Basudan, Breast Cancer Incidence Patterns in the Saudi Female Population: A 17-Year Retrospective Analysis, 2022, 58, 1648-9144, 1617, 10.3390/medicina58111617
    16. Mohammed A. AlJaffar, Sari S. Enani, Ahmad H. Almadani, Fay H. Albuqami, Khalid A. Alsaleh, Fahad D. Alosaimi, Determinants of quality of life of cancer patients at a tertiary care medical city in Riyadh, Saudi Arabia, 2023, 14, 1664-0640, 10.3389/fpsyt.2023.1098176
    17. Mohamed Ahmed Bealy, Awad Aljeed Abugooda, Ruba Mustafa Elsaid Ahmed, Nuha Abdel Rahman Khalil, Abdelbaset Mohamed Elasbali, Ghorashy Eltayeb Yousif Mohamed, Faris Merghani Eltom, Hussain Ahmed, Stephane Zingue, Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions, 2022, 2022, 1741-4288, 1, 10.1155/2022/2026284
    18. Hasan Ahmed H Baz, Saeed H. Halawani, Ibrahim Abdulaziz, Majid Ali, Nhal Ahmed Baz, Mohammed Jafal, Khaldoun Saleh, Regorafenib Adverse Drug Reactions among Patients in King Abdullah Medical City; A Chart Review Study, 2022, 11, 2277-3657, 24, 10.51847/IexPv4xRns
    19. Ahmad Almatroudi, Brain Tumors in Saudi Arabia: An Observational and Descriptive Epidemiological Analysis, 2022, 10, 2227-9032, 1796, 10.3390/healthcare10091796
    20. Firas S. Azzeh, Deena M. Hasanain, Alaa H. Qadhi, Khloud J. Ghafouri, Wedad F. Azhar, Mazen M. Ghaith, Abdullah F. Aldairi, Hussain A. Almasmoum, Hamza M. Assaggaf, Maha H. Alhussain, Ahmad A. Alghamdi, Mahmoud M. Habibullah, Waleed M. Bawazir, Sofyan S. Maghaydah, Maysoun S. Qutob, Awfa Y. Alazzeh, Consumption of Food Components of the Mediterranean Diet Decreases the Risk of Breast Cancer in the Makkah Region, Saudi Arabia: A Case-Control Study, 2022, 9, 2296-861X, 10.3389/fnut.2022.863029
    21. Sawsan Abdullah Alshahrani, Wedad Saeed Al-Qahtani, Nawaf Abdulrahman Almufareh, Dalia Mostafa Domiaty, Gadah Ibraheem Albasher, Fatmah Ahmed Safhi, Fatima Abdullah AlQassim, Mashael Alhumaidi Alotaibi, Tahani Mohamed Al-Hazani, Bassam Ahmed Almutlaq, Oral cancer among Khat users: finding evidence from DNA analysis of nine cancer-related gene mutations, 2021, 21, 1472-6831, 10.1186/s12903-021-01981-7
    22. Attiah Khobrani , Yasser Alatawi , Eshtyag Bajnaid, Omima Alemam, Abubakr Osman , Lina Bin Attash , Mohammed Jaffal , Mohammed AlGhanmi , Adnan Alharbi, Mohammed Alnuhait, Adherence to Hormonal Therapy in Breast Cancer Patients in Saudi Arabia: A Single-Center Study, 2022, 2168-8184, 10.7759/cureus.24780
    23. Hussain Gadelkarim Ahmed, Amel Bakri Mohammed El Hag, Khulaif Khalaf Alanazi, Hend M. Alkwai, Ahmed Mohmmed Ahmed Abdrhman, Abdelmuhsin Omer Ahmed Hassan, Ibrahim Abdelmageed Mohamed Ginawi, Abdelbaset Mohamed Elasbali, Hisham Sherfi, Histopathologic metrics of breast tumors in Northern Saudi Arabia, 2022, 15, 2689-5293, 649, 10.1080/26895293.2022.2082540
    24. Osamah Ahmad Hakami, Refah Asheer Alsubaie, Bayan Abdulhadi Albaqami, Haifa Matar Almutlaq, Nourah Mushabab Alqahtani, Manal Alkhonezan, Farah Fahad Almuqrin, Abdullah Hussien Alghamdi, Abdullah Abdulaziz Alaryni, Rayan Abubakker Qutob, Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward Helicobacter pylori, 2023, Volume 16, 1178-2390, 763, 10.2147/JMDH.S403999
    25. Majed Ramadan, Rwiah Alsiary, Noor Alsaadoun, Noara Alhusseini, Muhammad Raihan Sajid, Noor Mohamed Hamed, Tarek Ziad Arabi, Belal Nedal Sabbah, Risk of Breast Cancer Progression after Treatment in the Western Region of Saudi Arabia, 2023, 17, 1178-2234, 117822342311582, 10.1177/11782234231158270
    26. Ryanh H Alanazi, Anas Fathuldeen, Malik A Hussain, Ziyad Alharbi, Layan T Almazyad, Hadeel T Alanazi, Khulud Hamed S Alshammari, Shmoukh Mushref Alruwaili, Madhawi A Alanazi, Manal S Fawzy, Breast Cancer Knowledge and Associated Behaviors in Northern Borders, Saudi Arabia: A Cross-Sectional Study, 2024, 2168-8184, 10.7759/cureus.59893
    27. Mohammad H. Aljawadi, Nora Alkhudair, Marwan Alrasheed, Abdulaziz S. Alsuhaibani, Basil J. Alotaibi, Mansour Almuqbil, Abdullah M. Alhammad, Azhar Arafah, Farjah H. AlGahtani, Muneeb U. Rehman, Understanding the Quality of Life Among Patients With Cancer in Saudi Arabia: Insights From a Cross-Sectional Study, 2024, 31, 1073-2748, 10.1177/10732748241263013
    28. Shabihul Fatma Sayed, Hamad G. Dailah, Sumathi Nagarajan, Siddig Ibrahim Abdelwahab, Shaived S. Hasan Abadi, Nida Akhtar, Gulrana Khuwaja, Wadeah Ali DA Malham, Knowledge of Non-Invasive Biomarkers of Breast Cancer, Risk Factors, and BSE Practices Among Nursing Undergraduates in Farasan Island, KSA, 2024, 10, 2377-9608, 10.1177/23779608241248519
    29. Suha A Alhebshi, Safaa M Alsanosi, Hamsa S AlQashqri, Yosra Z Alhindi, Ghazi A Bamagous, Nahla A Ayoub, Alaa H Falemban, Toxicity of Nab-Paclitaxel Compared to Paclitaxel in a Tertiary Hospital in Jeddah, Saudi Arabia: A Retrospective Cohort Study, 2023, 2168-8184, 10.7759/cureus.39872
    30. Ahmed M Alessa, Abdul Sattar Khan, Epidemiology of Colorectal Cancer in Saudi Arabia: A Review, 2024, 2168-8184, 10.7759/cureus.64564
    31. Mohammed Erkhawan Hameed Rasheed, Mansour Youseffi, Luca Parisi, Farideh Javid, Saeed Afshin Javid, 2023, 2872, 0094-243X, 120015, 10.1063/5.0162992
    32. Afnan F Alshehri, Ahmed E Khodier, Mohammed M Al-Gayyar, Antitumor Activity of Ligustilide Against Ehrlich Solid Carcinoma in Rats via Inhibition of Proliferation and Activation of Autophagy, 2023, 2168-8184, 10.7759/cureus.40499
    33. Mohamed A Ghowinam, Ammar A Albokhari, Ahmed M Badheeb, Mohamed Lamlom, Mari Alwadai, Aseel Hamza, Ali Aladalah, Prevalence of Depression and Anxiety Symptoms Among Patients With Cancer in Najran, Saudi Arabia, 2024, 2168-8184, 10.7759/cureus.54349
    34. Turki M Alanzi, Wala Alzahrani, Nouf S Albalawi, Taif Allahyani, Atheer Alghamdi, ‏Haneen Al-Zahrani, ‏Awatif Almutairi, Hayat Alzahrani, Latifah Almulhem, Nouf Alanzi, Abdulrhman Al Moarfeg, ‏Nesren Farhah, Public Awareness of Obesity as a Risk Factor for Cancer in Central Saudi Arabia: Feasibility of ChatGPT as an Educational Intervention, 2023, 2168-8184, 10.7759/cureus.50781
    35. Omalkhair Abulkhair, Ahmad Omair, Dorothy Makanjuola, Manal Al Zaid, Lolwah Al Riyees, Nafisa Abdelhafiez, Emad Masuadi, Ghaida Alamri, Fatinah Althan, Abdulmohsen Alkushi, Ann Partridge, Breast Cancer in Young Women: Is It Different? A Single-Center Retrospective Cohort Study, 2024, 18, 1179-5549, 10.1177/11795549241228235
    36. Ahmed Alasker, Seham Alsalamah, Nada Alshathri, Nura Almansour, Faris Alsalamah, Mohammad Alghafees, Mohammad AlKhamees, Bader Alsaikhan, Performance of large language models (LLMs) in providing prostate cancer information, 2024, 24, 1471-2490, 10.1186/s12894-024-01570-0
    37. Nasser Al Shanbari, Abdulrahman Alharthi , Salah M Bakry, Muath Alzahrani, Majed M Alhijjy, Hashem A Mirza, Meshal Almutairi, Samar N Ekram, Knowledge of Cancer Genetics and the Importance of Genetic Testing: A Public Health Study, 2023, 2168-8184, 10.7759/cureus.43016
    38. Ali G Alghamdi, Alshareef M Alshareef, Aghnar T Alzahrani, Ziyad S Alharthi, Sarah S Alghamdi, Ahmed M Alghamdi, Faisal A Alzahrani, Reem A Alzahrani, Knowledge and Awareness About Gastric Cancer Among the General Population in Al-Baha City, Saudi Arabia, 2023, 2168-8184, 10.7759/cureus.39589
    39. Anwar Ali Jammah, Ibrahim Mohammed AlSadhan, Ebtihal Y. Alyusuf, Mubarak Alajmi, Abdullah Alhamoudi, Mohammed E. Al-Sofiani, The American Thyroid Association risk stratification and long-term outcomes of differentiated thyroid cancer: a 20-year follow-up of patients in Saudi Arabia, 2023, 14, 1664-2392, 10.3389/fendo.2023.1256232
    40. Turki Alelyani, Maha M. Alshammari, Afnan Almuhanna, Onur Asan, Explainable Artificial Intelligence in Quantifying Breast Cancer Factors: Saudi Arabia Context, 2024, 12, 2227-9032, 1025, 10.3390/healthcare12101025
    41. Sahar M Alnefaie, Mohammed A Alosaimi, Meshal F Althobaiti, Abdulmajeed A Altowairqi, Mohammed K Alrawqi, Sami M Alzahrani, Ghaliah O Alnefaie, Maryam S Aljaid, Analyzing Cardiovascular Characteristics of Patients Initially Diagnosed with Breast Cancer in Saudi Arabia, 2023, 2168-8184, 10.7759/cureus.45799
    42. Hamad Albagieh, Shaima E Alabdulkareem, Wajd Alharbi, Shahd M Alqahtani, Ghayda Algoblan, Oral Squamous Cell Carcinoma Mimicking Lichenoid Reaction After Implant Placement: A Case Report, 2023, 2168-8184, 10.7759/cureus.50804
    43. Naushad Abid, Abdullah H Bohamad, Hussain I Aljohar, Batla S Al Battat, Yousef Y Altaher, Abdulaziz E Alateeq, Maryam O Alarfaj, Meataz Aljeezan, Ali S AlBashrawi, Ahmed Al Jizan‎, Knowledge and Awareness of Leukemia Among the Population of Eastern Province, Saudi Arabia, 2023, 2168-8184, 10.7759/cureus.46382
    44. Mudassar Shahid, Ahmed L. Alaofi, Mohammed S. Alqahtani, Rabbani Syed, Genetic implications of PSMA expression variability in breast cancer subtypes with a focus on triple-negative breast cancer, 2024, 65, 1234-1983, 505, 10.1007/s13353-023-00814-3
    45. Hadi Afandi Al-Hakami, Jamelah F Altayyeb, Salwan M Alsharif, Mohammad A Alshareef, Baraa I Awad, Mohammed Al-Garni, Preoperative Thyroid-Stimulating Hormone Levels and Risk of Thyroid Cancer in Post-thyroidectomy Patients for Thyroid Nodules: A Study From a Tertiary Hospital in Western Saudi Arabia, 2023, 2168-8184, 10.7759/cureus.47622
    46. Usman Naseem, Junaid Rashid, Liaqat Ali, Jungeun Kim, Qazi Emad Ul Haq, Mazhar Javed Awan, Muhammad Imran, An Automatic Detection of Breast Cancer Diagnosis and Prognosis Based on Machine Learning Using Ensemble of Classifiers, 2022, 10, 2169-3536, 78242, 10.1109/ACCESS.2022.3174599
    47. Rayya A. Al-Balushi, Ashanul Haque, Mohd. Saeed, Thuraya Al-Harthy, Mohammed Al-Hinaai, Salim Al-Hashmi, Unlocking the Anticancer Potential of Frankincense Essential Oils (FEOs) Through Nanotechnology: A Review, 2024, 66, 1073-6085, 3013, 10.1007/s12033-023-00918-5
    48. Amal A. Alhaidary, Ahmad R. Al-Qudimat, Haitham Arabi, Raed M. Al-Zoubi, Imaging Patterns in Breast Cancer for Women Under 40 Years: A Descriptive Cohort Study, 2024, 14, 2210-6014, 63, 10.1007/s44197-023-00169-2
    49. Mohammed Ali Abutalib, Anwar Shams, Shadi Tamur, Eman A. Khalifa, Ghaliah Obaid Alnefaie, Yousef M. Hawsawi, Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature, 2023, 17, 1752-1947, 10.1186/s13256-023-04265-6
    50. Muhannad Faleh Alanazi, Ashokkumar Thirunavukkarasu, Maily Alrowily, Nouf Alaqel, Abdulelah Alaqel, Mutlaq Alruwaili, Nouf Nashmi M Alazmi, Osamah Alhassan, Mona Fahad M Aljarallah, Afrah Mohaimeed Altaymani, A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study, 2023, Volume 15, 1179-1314, 451, 10.2147/BCTT.S414635
    51. Meaad F Alatawi, Abdulaziz Al-Saif, Fahad D Alosaimi, Role of Psychosomatic Medicine in Complex Medical Cases: A Case Study of a Patient With Breast Cancer Who Refused Mastectomy, 2024, 2168-8184, 10.7759/cureus.61343
    52. Nawaf Alhindi, Basma Bamakhrama, Anas Alzahrani, Hatan Mortada, Nashwa M. Ali, Abdullah Alruwaili, Noor Baamir, Hattan Aljaaly, Risk factors of implant loss and complications post-implant based breast reconstruction: A meta-analysis, 2023, 46, 1435-0130, 865, 10.1007/s00238-023-02077-x
    53. Hanan A Albenayyan, Renad AlSubaie, Maryam O Alarfaj, Lames Alshekhmobarak, Mohammed F Alkhalifah, Hajar Alsaleem, Dalal Almulhim, Aisha A AlJughaiman, Fatimah A Albahrani, Almaha A Aleidan, Razan M Alzahrani, Lama Alobaid, Taghreed Alhinidi, Cancer Stigma Among 800 Saudi Citizens: A Cross-Sectional Study and Literature Review, 2023, 2168-8184, 10.7759/cureus.49088
    54. Musa AlHarbi, Nahla Ali Mobark, Wael Abdel Rahman AlJabarat, Hadeel ElBardis, Ebtehal AlSolme, Abdullah Bany Hamdan, Ali H. AlFakeeh, Fatimah AlMushawah, Fawz AlHarthi, Abdullah A. AlSharm, Ali Abdullah O. Balbaid, Naji AlJohani, Alicia Y. Zhou, Heather A. Robinson, Saleh A. Alqahtani, Malak Abedalthagafi, Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel, 2023, 14, 1949-2553, 580, 10.18632/oncotarget.28457
    55. Badr Alharbi, Hatim S Alnosayan, Faisal Awadh Al-Harbi, Alwleed M Alaidah, Albaraa Nasser Almoshiqeh, Abdullah Mulfi Alharbi, Emad Alwashmi, Adil Khalaf Altwairgi, Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study, 2024, 2168-8184, 10.7759/cureus.72748
    56. Mussab A Barkar, Zaher Mikwar, Adil A Khalid, Ali A Mohammedamin, Abdulrahman H Aloufi, Abdulmajeed A Abualhamail, Hamad A Alghashim, Patient Satisfaction and Quality of Life After Mastectomy at King Abdulaziz Medical City, Jeddah, 2023, 2168-8184, 10.7759/cureus.51029
    57. RUPA R, PAVITHRA B, KAVYA M, NIKHITHA K V, NIVETHA J D, Bindhu J, Evaluation of Anticancer Activity and Structural Analysis of Biosynthesized Silver Nanoparticles (AgNPs) from Centella Asiatica, 2024, 17, 0974-3278, 7256, 10.37285/ijpsn.2024.17.2.7
    58. Mahvish Khan, Nashwa Z.A. Bushara, Manoj Kumar, Raju K. Mandal, Saheem Ahmad, Saif Khan, Frequency of Healthy Control Genotype of VDR Gene Polymorphisms in the Saudi Population of the Ha'il Region: A Comparative Study with Worldwide Population , 2024, 43, 0731-8898, 61, 10.1615/JEnvironPatholToxicolOncol.2023048813
    59. Mohammed Omar, Ali Alnahdi, Psychometric Properties and Factorial Analysis of the Arabic McGill-QoL Questionnaire in Breast Cancer, 2023, Volume 15, 1179-1314, 813, 10.2147/BCTT.S422369
    60. Ghala Yasin, Abeer A Subke, Breast Cancer Screening Awareness and Associated Factors Among Saudi Females: A Cross-Sectional Study in Jeddah, Saudi Arabia (2024), 2024, 2168-8184, 10.7759/cureus.60337
    61. Mehenaz Hanbazazh, Abdulhadi Samman, Saad Samargandy, Jaudah Al-Maghrabi, Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma, 2023, 18, 1993-2820, 10.1080/19932820.2023.2283953
    62. Ahmed Saad AL Zomia, Ibrahim Ali M AL Zehefa, Lama Ali Lahiq, Mohammed Tarek Mirdad, Abdullah Saad Alshahrani, Turki Alshahrani, Nawaf N. Almahfuth, Mahmoud Tarek Mirdad, Albara Awad Alqarni, Noor Mohamed Alshareef, Ryan M. AL Qahtani, Mohammed Abdulrahman Asiri, Mohammed Saad Alshahrani, Ramy Mohamed Ghazy, Ibrahim Tawhari, Tracking the epidemiological trends of female breast cancer in Saudi Arabia since 1990 and forecasting future statistics using global burden of disease data, time-series analysis, 2024, 24, 1471-2458, 10.1186/s12889-024-19377-x
    63. Ahmed M Badheeb, Fasal Ahmed, Musadag Elhadi, Nasher Alyami, Mohamed A Badheeb, Clinical and Therapeutic Profile of Non-Hodgkin’s Lymphoma: A Retrospective Study From a Najran Oncology Center, 2023, 2168-8184, 10.7759/cureus.40125
    64. Mohmmed M. Aljeldah, Talat A. El-kersh, Mourad A.M. Aboul-Soud, Parasporins of Bacillus thuringiensis Strain Exhibit Apoptosis-Mediated Selective Cytotoxicity to MDA-MB-231 Cells through Oxidative Stress, 2024, 18, 09737510, 1305, 10.22207/JPAM.18.2.51
    65. Jehad Alzahrani, Suhaib Radi, Abdullah Aljabri, Mohammad Alandejani, Advanced Unresectable Differentiated Thyroid Cancer With Anaplastic Transformation: A Case Report and Review of the Literature, 2024, 2168-8184, 10.7759/cureus.73956
    66. Moath A. Alfaleh, Omar A. Alanzi, Mohammed F. Alzamil, Fatmah A. Alabdulwahid, Turki M. AlMuhaimid, Association Between Vitamin D Deficiency and Papillary Thyroid Cancer: Tertiary Center Experience, 2024, 2231-3796, 10.1007/s12070-024-05225-2
    67. Dalia A. Elmaghraby, Ahmad Mohammed Al ben Hamad, Khalid Mohammed Alhunfoosh, Hamzah Redha Alturifi, Mohammed Abdullah Albahrani, Ahmed Ali Alshalla, Anas Alyahyan, Muntathir Altaweel, Exploration and Assessment of Breast Cancer Awareness in the Saudi Population: A Cross-Sectional Study, 2023, 50, 0390-6663, 10.31083/j.ceog5011245
    68. Ahmed M. Aljameeli, Most Prevalent Cancer Subtypes in Saudi Arabia, 2024, 0974-360X, 5457, 10.52711/0974-360X.2024.00835
    69. Abdullah U. Althemery, Rawan Alzahrani, Nura Alajlan, Abdullah M. Alrajhi, Quality of life for patients on oncology treatments in the Kingdom of Saudi Arabia: a systematic review, 2025, 18, 2052-3211, 10.1080/20523211.2024.2449036
    70. F. H. Khathayer, M. H. Mikael, S. Z. Kadhim, Epidemiology of the most Prevalent Cancers in Ninewa between 2017–2021, 2025, 23, 2619-0494, 34, 10.31631/2073-3046-2024-23-6-34-46
    71. Waad Moied Althaqfi, Shahad Hassan Alshahrani, Mjd Mohammed Alanazi, Rahaf Ali Sharahili, Mona Qushawy, Yasmin Mortagi, Huda M. Atif, Kousalya Prabahar, Mansuor A. Alanazi, Mody Albalawi, Zuhair M. Mohammedsaleh, Rehab Ahmed, Nehal Elsherbiny, Development and optimization of flaxseed oil nanoemulsions: implications for ulcerative colitis treatment, 2025, 0193-2691, 1, 10.1080/01932691.2025.2456530
    72. Faisal Aljadani, Reem Nughays, Ghaida Alharbi, Enar Almazroy, Shahad Elyas, Hala Danish, Rimaz Alanazi, Badr Aldrees, Galia Jadkarim, Zaher Mikwar, Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review, 2025, Volume 17, 1179-1314, 171, 10.2147/BCTT.S505725
    73. Mansour Alsaleem, Samar Sindi, Safiah Alhazmi, Sabah Hassan, Magdah Ganash, Najla Alburae, Shadi Alkhayyat, Ayman Linjawi, Aisha Elaimi, Saif A. Alharthy, Khloud Algothmi, Reem Farsi, Ghadeer Alrefaei, Nouf Alsubhi, Norah Hamdi, Heba Alkhatabi, Deciphering the prognostic impact of aberrant DNA methylation on ANGPT1 gene in breast cancer, 2025, 15, 2045-2322, 10.1038/s41598-025-90001-7
    74. Doha Mohammed Rayed Fatani, Tusneem Elhassan, Narmeen Shaikh, Noara Alhusseini, Linking local cancer registries and national death records: a crucial step for accurate survival data in Saudi Arabia, 2025, 25, 1472-6963, 10.1186/s12913-025-12716-7
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6991) PDF downloads(1275) Cited by(19)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog